Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conference Coverage Conference Listing
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story
Subscribe
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
LeukemiaLeukemiaLeukemia
Lung Cancer
LymphomaLymphomaLymphomaLymphoma
Rare CancersRare Cancers
Sarcoma
Skin Cancer/Melanoma
Thyroid Cancer
Spotlight -
  • Blogs
  • Breast Cancer Webinar Series
  • Cancer Horizons
  • Clinical Trial Corner
  • Heal®
  • Publications
  • Videos
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
LeukemiaLeukemiaLeukemia
Lung Cancer
LymphomaLymphomaLymphomaLymphoma
Rare CancersRare Cancers
Sarcoma
Skin Cancer/Melanoma
Thyroid Cancer
    • Subscribe
Advertisement

Jason R. Gotlib

home / contributors / jason-r-gotlib

Articles


Jason R. Gotlib on JAK Inhibitors for the Treatment of Myelofibrosis

Jason R. Gotlib on JAK Inhibitors for the Treatment of Myelofibrosis

Jason R. Gotlib
March 23rd 2016

Jason R. Gotlib discusses JAK inhibitors for the treatment of patients with myelofibrosis.

Read More


Jason R. Gotlib Discusses MPN Research at Stanford

Jason R. Gotlib Discusses MPN Research at Stanford

Jason R. Gotlib
December 22nd 2015

Jason R. Gotlib discusses the research being done at his institution. Gotlib is a 2015 MPN Hero in the category of Commitment to the Individual and is also an international leader in MPN research.

Read More

Latest Updated Articles

This guide provides an overview of bladder cancer, from diagnosis to treatment, helping patients understand options, manage side effects, and plan care: © stock.adobe.com.
Published: August 22nd 2025 | Updated: August 25th 2025
Understanding Bladder Cancer: Types, Diagnosis and Treatment Options
Breast cancer types, staging, genetics, diagnosis, treatment, and survivorship are complex, but understanding them helps patients make informed care decisions.
Published: August 22nd 2025 | Updated: August 25th 2025
Breast Cancer: What You Need to Know About Types, Staging and Genetics
Early-stage kidney cancer is limited to the kidney, usually under seven centimeters and often has a very good prognosis when treated promptly.
Published: August 22nd 2025 | Updated: August 25th 2025
Navigating Your Early-Stage Kidney Cancer Diagnosis
Image of man and doctor.
Published: April 12th 2025 | Updated: July 2nd 2025
NeuroSAFE May Preserve Erectile Function After Prostate Cancer Surgery
Image of doctor consulting patient.
Published: February 5th 2025 | Updated: May 19th 2025
Erleada Combo Shows Comparable Quality of Life Outcomes in Prostate Cancer
Image of three icons related to multiple myeloma.
Published: November 5th 2024 | Updated: May 19th 2025
Carvykti Effective in Real-World Setting for Myeloma
About Us
Advertise / Support
Editorial Board
Contact Us
CancerNetwork.com
TargetedOnc.com
OncLive.com
OncNursingNews.com
Terms & Conditions
Privacy
Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.